Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Phase 2/3

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

NCT07819435 · tracked via the Priya Life Science USA tracker
Sponsor
Pelage Pharmaceuticals, Inc
Phase
Phase 2/3
Started
2026-09-21
Last updated
2026-10-28

Condition(s) studied

Androgenetic Alopecia

Investigational drug(s) / intervention(s)

PP405 0.05% Topical Gel →Vehicle Topical Gel

PP405 0.05% Topical Gel: Medicated topical gel containing PP405 0.05%

Vehicle Topical Gel: Topical gel

Study summary

The study is designed to validate efficacy and long term safety of PP405.

Eligibility

Sex
MALE
Min age
18 Years
Max age
55 Years
Healthy volunteers
No
Inclusion Criteria: 1. Males (assigned at birth) aged 18 to 55 years, inclusive at time of consent. 2. Able and willing to provide written informed consent 3. Must have been experiencing Androgenetic Alopecia (AGA) for at least 6 months prior to screening. 4. Have a modified Norwood-Hamilton score of Type IV or Type V 5. Agree to comply with protocol procedures Exclusion Criteria: 1. Concomitant diagnosis of non-AGA forms of alopecia. 2. Use of other hair loss treatments within periods specified in protocol. 3. Use of excluded medications and procedures as specified in protocol. 4. Diagnosis of other medical conditions as specified in protocol. 5. Any disease or medical condition that, in the opinion of the Investigator, would prevent the subject from participating in the study or might confound study results.

Primary outcome measure(s)

  • Change from baseline in non-vellus target area hair count — Week 24
    Change from baseline in non-vellus target area hair count (nvTAHC) at the vertex

Trial sites (63)

FacilityCityRegionStatus
AllerVie Clinical Research Birmingham Alabama Recruiting
Cahaba Dermatology & Skin Health Center Birmingham Alabama Recruiting
Johnson Dermatology Fort Smith Arkansas Recruiting
Burke Pharmaceutical Research Hot Springs Arkansas Recruiting
Northwest Arkansas Clinical Trials Center/Hull Dermatology P.A. Rogers Arkansas Not Yet Recruiting
First OC Dermatology Research, Inc. Fountain Valley California Not Yet Recruiting
Ablon Skin Institute and Research Center Manhattan Beach California Recruiting
Quest Dermatology Research Northridge California Not Yet Recruiting
Integrative Skin Science and Research Sacramento California Not Yet Recruiting
TCR Medical Corporation San Diego California Not Yet Recruiting
Clinical Trials Research Institute Thousand Oaks California Recruiting
Skin Care Research, LLC Boca Raton Florida Recruiting
Skin Research Institute, LLC Coral Gables Florida Recruiting
MOORE Clinical Research, Inc. Tampa Florida Recruiting
Research Institute of the Southeast West Palm Beach Florida Recruiting
DelRicht Research (Experience Dermatology) Atlanta Georgia Recruiting
Cleaver Medical Group Dermatology, Inc Dawsonville Georgia Not Yet Recruiting
Ada West Research Meridian Idaho Not Yet Recruiting
DS Research of Southern Indiana, LLC Clarksville Indiana Not Yet Recruiting
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana Recruiting
Indiana Clinical Trials Center Plainfield Indiana Recruiting
Equity Medical Bowling Green Kentucky Not Yet Recruiting
DS Research of Kentucky, LLC Louisville Kentucky Not Yet Recruiting
DelRicht Research @LA Dermatology Associates Baton Rouge Louisiana Recruiting
Clinical Trials Management, LLC Metairie Louisiana Not Yet Recruiting
DelRicht Research New Orleans Louisiana Recruiting
Brigham and Woman's Hospital Boston Massachusetts Not Yet Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts Not Yet Recruiting
Great Lakes Research Group Inc. Bay City Michigan Not Yet Recruiting
Michigan Center for Skin Care Research Clinton Township Michigan Recruiting
Revival Research Institute, LLC Troy Michigan Recruiting
Minnesota Clinical Study Center New Brighton Minnesota Recruiting
DelRicht Research (Town Center Dermatology) Wildwood Missouri Recruiting
The Skin Center Dermatology Group New City New York Not Yet Recruiting
Marc Avram, MD Office New York New York Not Yet Recruiting
Equity Medical, LLC New York New York Recruiting
Equity Medical The Bronx New York Recruiting
Vitality Clinical Trials LLC Woodbury New York Recruiting
WDC Cosmetic and Research, PLLC Wilmington North Carolina Not Yet Recruiting
Bexley Dermatology Research/Dermatologists of Southwestern Ohio Bexley Ohio Not Yet Recruiting

+ 23 more sites — see the full list on the official registry below.

More Pelage Pharmaceuticals, Inc. trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07819435 on ClinicalTrials.gov ↗ ← All trials in the USA